Guizhou Yibai Pharmaceutical (600594.SH) released the third quarter report for 2024, with the company's revenue in the first three quarters of the year at 17...
According to the Zhitong Finance APP, Guizhou Yibai Pharmaceutical (600594.SH) released the third quarter report for 2024, with the company's revenue in the first three quarters of the year at 1.714 billion yuan, a year-on-year decrease of 19.80%; net loss attributable to the shareholders of the listed company was 0.169 billion yuan; net loss attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 0.18 billion yuan; basic loss per share was 0.214 yuan/share.